Drug intelligence / Profile preview

azulene

Development stage
Unknown
Modality
Small Molecules
Administration
Topical, Ophthalmic
01

Overview

Azulene is an aromatic organic compound and a structural isomer of naphthalene that is notable for its deep blue color[8]. It has been used in medicine primarily for its anti-inflammatory and soothing properties[4][5][1]. Azulene and its derivatives are found in nature (e.g., chamomile oil) and have a long history of use as chromophores in plant extracts[8]. In pharmaceutical applications, azulene acts as a non-steroidal anti-inflammatory agent with additional analgesic and antipyretic effects; it works mainly by inhibiting cyclooxygenase 2 enzymes (especially COX-2), thereby reducing prostaglandin synthesis involved in inflammation[4][5]. Azulene also stabilizes cell membranes and modulates cytokine secretion to further limit inflammatory responses[5]. Clinically or cosmetically it is used topically to soothe irritated or inflamed skin (as in creams/ointments) or ophthalmically to treat eye inflammation such as conjunctivitis or keratitis[1][7]. Various azulene derivatives are under investigation for broader therapeutic uses including peptic ulcer disease, leukemia (via Fms-like tyrosine kinase 3 inhibition), diabetes mellitus complications, HIV infection (antiretroviral activity), antimicrobial photodynamic therapy, antifungal therapy, and erectile dysfunction through different mechanisms involving tyrosine kinase inhibition or receptor modulation[3][5]. Azulene itself serves more often as a scaffold for drug development than as an active pharmaceutical ingredient; many marketed products contain azulene derivatives rather than pure azulene. Its most established clinical use is topical/ophthalmic anti-inflammation.

Other names
Bicyclo-(5.3.0)-deca-2,4,6,8,10-pentaeneBicyclo-(0.3.5)-deca-1,3,5,7,9-pentaene
02

Targets

PTGS2 (Prostaglandin-Endoperoxide Synthase 2)FLT3 (Fms related receptor tyrosine kinase 3)

Beyond the preview

Go deeper on azulene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on azulene.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call